Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma.
Zanetti
Eleonora
E
Barozzi
Patrizia
P
Brown
Elizabeth E
EE
Bosco
Raffaella
R
Vallerini
Daniela
D
Riva
Giovanni
G
Quadrelli
Chiara
C
Potenza
Leonardo
L
Forghieri
Fabio
F
Montagnani
Giuliano
G
D'Amico
Roberto
R
Del Giovane
Cinzia
C
Duraes
Cecilia
C
Whitby
Denise
D
Machado
Jose C
JC
Schulz
Thomas F
TF
Torelli
Giuseppe
G
Luppi
Mario
M
D020413:3' Untranslated Regions; D020121:5' Untranslated Regions; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D019288:Herpesvirus 8, Human / Q000472:pathogenicity; D006801:Humans; D007558:Italy; D015810:Linkage Disequilibrium; D016015:Logistic Models; D008875:Middle Aged; D016017:Odds Ratio; D016377:Organ Transplantation / Q000009:adverse effects*; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D018570:Risk Assessment; D012307:Risk Factors; D012514:Sarcoma, Kaposi / Q000235:genetics* / Q000821:virology; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*; D055815:Young Adult
D020413:3' Untranslated Regions; D020121:5' Untranslated Regions; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A